Condition 1: Breast cancer. Condition 2: Lung cancer. Condition 3: Prostate cancer. Condition 4: Liver cancer. Condition 5: Colon cancer. Condition 6: Stomach cancer. Condition 7: Uterus cancer. Condition 8: Bladder cancer. Malignant neoplasm of breast Malignant neoplasm of bronchus and lung Malignant neoplasm of prostate Liver cell carcinoma Malignant neoplasm of colon Malignant neoplasm of stomach Malignant neoplasm of uterus, part unspecified Malignant neoplasm of bladder
Conditions
Interventions
Intervention 1: Intervention group: nebulized group, received nebulization of 20-mg Morphine, repeated every 10minutes with a maximum of 3 nebulizations. Intervention 2: Intervention group: Fentanyl g
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Suffering from moderate or severe pain Patient awareness about his/her situation and illness Suitable Glasgow Coma Scale (GCS) for patient cooperation
Exclusion criteria
Exclusion criteria: Allergy to Opioids Hypotension(Systolic Blood pressure lower than 110 mmHg) Bradypnea (respiration rate less than 12 times per minutes) Hypoxemia (Oxygen saturation lower than 90 percent in room temperature) Rhinitis Liver and kidney disorders Hypothyroidism Prostate hypertrophy Addison's disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: At the beginning of the study (before the intervention) and at the beginning and end of each day for 3 days. Method of measurement: Visual Analog Score that is numbered from 0 to 10. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahdi Ebrahini
Esfahan University of Medical Sciences
Outcome results
None listed